Insider Trading - IMPEL NEUROPHARMA INC (IMPL)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for IMPEL NEUROPHARMA INC

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-04-27
Purchase
2021-04-29
5:07 pm
IMPEL NEUROPHARMA INC IMPL KKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
1,100,000 $15 $16,500,000 3,802,638
(Indirect)
View
2021-04-27
Purchase
2021-04-29
6:44 pm
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
450,000 $15 $6,750,000 2,759,791
(Direct)
View
2021-04-27
Purchase
2021-04-29
7:45 pm
IMPEL NEUROPHARMA INC IMPL Norwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
825,000 $15 $12,375,000 3,077,198
(Direct)
View
2021-04-27
Purchase
2021-04-29
8:51 pm
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
575,000 $15 $8,625,000 575,000
(Indirect)
View
2021-04-27
Purchase
2021-04-29
9:10 pm
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
575,000 $15 $8,625,000 349,674
(Indirect)
View
2021-08-18
Purchase
2021-08-19
5:23 pm
IMPEL NEUROPHARMA INC IMPL ADAMS ADRIAN
CEO
20,000 $13.99 $279,790 20,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-04-22
Other
2021-04-26
5:55 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,359,799 $0 1,359,799
(Indirect)
View
2021-04-22
Other
2021-04-26
6:01 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
3,637 $0 3,637
(Direct)
View
2021-04-22
Other
2021-04-26
6:24 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,194,786 $0 1,194,786
(Indirect)
View
2021-04-22
Other
2021-04-26
6:24 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
165,013 $0 165,013
(Indirect)
View
2021-04-22
Other
2021-04-26
7:02 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL Norwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
1,325,893 $0 1,325,893
(Direct)
View
2021-04-22
Other
2021-04-26
7:11 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
1,359,799 $0 1,359,799
(Direct)
View
2021-04-27
Conversion
2021-04-29
5:07 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL KKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
2,583,926 $0 2,583,926
(Indirect)
View
2021-04-27
Other
2021-04-29
5:07 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL KKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
118,712 $13.5 2,702,638
(Indirect)
View
2021-04-27
Conversion
2021-04-29
5:07 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL KKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
42,307,448 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
4,523 $0 108,496
(Direct)
View
2021-04-27
Other
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
275 $0 108,221
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
8,523 $8.19 0
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
8,523 $0 69,657
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
69,657 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
3,732 $0 3,732
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
7,355 $0 11,087
(Direct)
View
2021-04-27
Other
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
458 $0 10,629
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
8,793 $0 19,422
(Direct)
View
2021-04-27
Other
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
1,666 $0 17,756
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
271 $13.5 18,027
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
61,109 $0 0
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
13,756 $8.19 0
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
13,756 $0 120,447
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
120,447 $0 0
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
47,263 $8.66 0
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
47,236 $0 143,986
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
143,986 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
3,637 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
2,309,791 $0 2,309,791
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
5,876,034 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
8,201,930 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
8,845,942 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
13,233,885 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
1,359,799 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
7:45 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Norwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
98,927 $13.5 98,927
(Direct)
View
2021-04-27
Conversion
2021-04-29
7:45 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Norwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
2,153,271 $0 2,252,198
(Direct)
View
2021-04-27
Conversion
2021-04-29
7:45 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL Norwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
1,325,893 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
7:45 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Norwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
35,256,208 $0 0
(Direct)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
808,259 $0 808,259
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
540,265 $0 1,348,524
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
500,932 $0 1,849,456
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
358,878 $0 2,208,334
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
101,457 $13.5 2,309,791
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
13,233,885 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
8,845,942 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
8,201,930 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
5,876,034 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL 5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
1,359,799 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
710,190 $0 710,190
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
98,068 $0 98,068
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
474,713 $0 1,184,903
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
65,552 $0 163,620
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
440,119 $0 1,625,022
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
60,813 $0 224,433
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
315,328 $0 1,940,350
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
43,550 $0 267,983
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
89,145 $13.5 2,029,495
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
12,311 $13.5 280,294
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
11,628,174 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,605,711 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
7,772,634 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,073,308 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
7,206,216 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
995,714 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
5,162,969 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
713,064 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,194,786 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
165,013 $0 0
(Indirect)
View
2021-04-27
Conversion
2021-06-07
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
4,253 $0 108,496
(Direct)
View
2021-04-27
Conversion
2021-06-07
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
69,657 $0 0
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:05 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INC IMPL Allison David D.
Director
11,500 $0 11,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:06 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INC IMPL NELSON TIMOTHY S
Director
11,500 $0 11,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:09 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INC IMPL PARKER H STEWART
Director
11,500 $0 11,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:10 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INC IMPL SHAH MAHENDRA
Director
11,500 $0 11,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:12 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INC IMPL Wilfong Diane E.
Director
11,500 $0 11,500
(Direct)
View
2021-07-20
Option Award
2021-07-26
5:58 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INC IMPL ADAMS ADRIAN
CEO
50,000 $0 50,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
5:58 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INC IMPL Hoekman John
Chief Scientific Officer
50,000 $0 50,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
6:00 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INC IMPL Leaman John Harold
CFO
50,000 $0 50,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
6:02 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INC IMPL Paolillo Leonard
Chief Commercial Officer
30,000 $0 30,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
6:04 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
50,000 $0 50,000
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
14,780 $1.97 14,780
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
4,650 $2.46 19,430
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
53,954 $2.95 73,384
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
2027-10-17
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
14,780 $0 0
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
2028-03-08
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
4,650 $0 541
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
2029-02-07
IMPEL NEUROPHARMA INC IMPL SHREWSBURY STEPHEN B
Chief Medical Officer
53,954 $0 29,587
(Direct)
View
2021-10-19
Option Award
2021-10-21
5:31 pm
N/A
2031-10-19
IMPEL NEUROPHARMA INC IMPL Leaman John Harold
CFO
10,571 $0 10,571
(Direct)
View